LA HEALTHCARE
Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Charting Medical Course
Retired doctor serves as consultant advising patients on treatments.Retired doctor’s advocacy service speaks to patients looking to navigate medical process. May 14, 2012 midnight $$ ShareSkechers to Pay $45 Million in Deceptive Advertising Case
Skechers USA Inc. has agreed to pay about $45 million to settle charges by federal and state regulators that the company made overhyped advertising claims that its Shape-ups shoes would help people lose weight and tone muscles faster.
CytRx Plans Reverse Stock Split
Cancer drug developer CytRx Corp. announced a reverse split of its common stock that should help the company become compliant with Nasdaq listing requirements.
Herbalife Shares Plunge on Outlook, Analyst’s Questions
Herbalife Ltd. reported a better-than-expected quarterly profit as it sold more products across all its regions. But shares plummeted 20 percent Tuesday after the company forecast second-quarter earnings below estimates and a noted hedge fund investor questioned some of the company’s disclosures.
Molina Healthcare’s Quarter Beats Expectations
Molina Healthcare Inc. said that its first quarter net income rose a better-than-expected 4 percent, largely from expansion of its health insurance business in Texas.
MannKind Licenses Experimental Drugs to Utah Company
MannKind Corp. announced that it is licensing a portfolio of early-stage experimental drugs to Tolero Pharmaceuticals Inc. in a deal that could be worth more than $130 million.
On Assignment Reports Strong Quarter
Shares of On Assignment Inc. gained 8 percent on Friday after the specialty staffing firm said its first quarter profit jumped 54 percent on strong growth in all the industries it serves.
FDA Rejects Amgen's Application for New Xgeva Use
U.S. regulators have rejected an application by Amgen Inc to expand the use of its drug Xgeva to slow the spread of tumors to the bones of patients suffering from advanced prostate cancer.
Amgen to Buy Turkish Pharma Company
Amgen Inc. plans to acquire Turkish generic drug maker Mustafa Nevzat Pharmaceuticals for nearly $700 million cash, in a bid to expand its overseas business.
Amgen’s Quarter Beats Wall Street Forecasts
Amgen Inc.'s first-quarter profit rose 5 percent on higher sales of its two biggest drugs and two new products, easily beating Wall Street forecasts.
Security Sales Boost Strong Quarter for OSI Systems
OSI Systems Inc.'s fiscal third-quarter net income jumped 43 percent as revenue from its large security scanner division rose 27 percent.
Body Scanner Maker Sees Medical Devices As Sales Shot in Arm
OSI sees medical devices as healthy additions to its airport and cargo security scanning business.
Puma Biotechnology to Begin Trading Shares
Puma Biotechnology Inc., the cancer drug developer founded by former Cougar Biotechnology Chief Executive Alan Auerbach, said it will begin trading shares on the OTC Bulletin Board on Wednesday.
Molina Healthcare Appeals Exclusion from Ohio’s Medicare Program
Molina Healthcare Inc. said that its Ohio health plan has filed a formal protest of its exclusion from Ohio's Medicaid managed care program.
L.A. Forges Healthier Bonds With Biomed Industry
Firms no longer leaving area after being acquired by larger rivals.
L.A. is seeing healthy returns from biomed companies that no longer depart after being acquired.
-
prev
- next
>>